Geller H M, Hoffer B J, Taylor D A
Fed Proc. 1980 Oct;39(12):3016-23.
Electrophysiological investigations have revealed that benzodiazepines, applied either locally or systemically, reduce central nervous system excitability. The studies summarized here indicate that this depression of excitability by benzodiazepines is a result of an increase in gamma-aminobutyric acid (GABA) mediated inhibition. This increase in inhibition may result from benzodiazepines increasing the activity of some GABAergic neurons and also from a modulatory action of benzodiazepines on GABA actions at some postsynaptic receptor sites. The modulatory action is observed with doses of benzodiazepines that do not cause any direct effects on neuronal excitability or membrane polarization. Specificity tests indicate that benzodiazepines do not enhance inhibition mediated by glycine or monoamines such as norepinephrine or serotonin. Results of experiments with a convulsant benzodiazepine compound, which causes a specific reduction in GABA-mediated inhibition, are also presented, The data are discussed in terms of a model in which the benzodiazepine receptor, the GABA receptor, and the chloride ionophore are functionally linked. Furthermore, it is proposed that some postsynaptic actions of GABA may be continually regulated by the occupancy of a benzodiazepine receptor, and that occupancy of the benzodiazepine receptor may be permissive for the GABA-elicited increase in chloride ion permeability.
电生理研究表明,无论是局部应用还是全身应用,苯二氮䓬类药物均可降低中枢神经系统的兴奋性。此处总结的研究表明,苯二氮䓬类药物对兴奋性的这种抑制作用是γ-氨基丁酸(GABA)介导的抑制作用增强的结果。这种抑制作用的增强可能是由于苯二氮䓬类药物增加了某些GABA能神经元的活性,也可能是由于苯二氮䓬类药物对某些突触后受体部位的GABA作用具有调节作用。在使用对神经元兴奋性或膜极化没有任何直接影响的苯二氮䓬类药物剂量时,可观察到这种调节作用。特异性测试表明,苯二氮䓬类药物不会增强由甘氨酸或单胺类(如去甲肾上腺素或5-羟色胺)介导的抑制作用。还介绍了一种惊厥性苯二氮䓬类化合物的实验结果,该化合物可导致GABA介导的抑制作用特异性降低。根据苯二氮䓬受体、GABA受体和氯离子载体在功能上相互联系的模型对数据进行了讨论。此外,有人提出,GABA的某些突触后作用可能会受到苯二氮䓬受体占据情况的持续调节,并且苯二氮䓬受体的占据可能允许GABA引起的氯离子通透性增加。